4530 — Hisamitsu Pharmaceutical Co Income Statement
0.000.00%
- ¥300bn
- ¥181bn
- ¥142bn
- 90
- 43
- 81
- 87
Annual income statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 29th, JPY millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 140,992 | 114,510 | 120,193 | 128,330 | 141,706 |
Cost of Revenue | |||||
Gross Profit | 87,604 | 69,173 | 70,067 | 72,700 | 78,971 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 117,785 | 103,837 | 111,136 | 116,942 | 129,385 |
Operating Profit | 23,207 | 10,673 | 9,057 | 11,388 | 12,321 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26,155 | 12,197 | 12,956 | 16,113 | 19,186 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18,911 | 9,433 | 9,863 | 12,126 | 14,432 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18,694 | 9,251 | 9,659 | 11,743 | 13,971 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18,694 | 9,250 | 9,658 | 11,742 | 13,969 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 223 | 111 | 122 | 147 | 191 |
Dividends per Share | |||||
Special Dividends per Share |